GENE ONLINE|News &
Opinion
Blog

2022-05-19| Special

RNA Therapeutics Beyond Vaccines

by Sahana Shankar
Share To
photo credit to ASCGT
At the 25th annual meeting of the American Society for Gene and Cell Therapy (ASGCT), researchers from industry and academia shared their experience in developing RNA drugs for various applications and improving their efficacy, targeting, and specificity.

Dr. Hamideh Parhiz from the University of Pennsylvania spoke of optimizing the lipid nanoparticles (LNPs) for in vivo delivery of mRNA therapeutics and Dr. Lisa Rice discussed the various strategies for developing mRNA therapeutics for rare diseases at Moderna Therapeutics.

It's free! Log in now to read

LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top